From asbestos exposure to carcinogenesis: Transcriptomic signatures in malignant pleural mesothelioma
Authors:
Open Access
- 20 May 2025
- journal article
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 143, 104973
Abstract
No abstract availableKeywords
Funding Information
- National Institute for Insurance against Accidents at Work
This publication has 43 references indexed in Scilit:
- Aberrant expression of NPPB through YAP1 and TAZ activation in mesothelioma with Hippo pathway gene alterationsCancer Medicine, 2023
- Ferroptosis-dependent extracellular vesicles from macrophage contribute to asbestos-induced mesothelial carcinogenesis through loading ferritinRedox Biology, 2021
- Asbestos conceives Fe(II)-dependent mutagenic stromal milieu through ceaseless macrophage ferroptosis and β-catenin induction in mesotheliumRedox Biology, 2020
- Alpha synuclein aggregation drives ferroptosis: an interplay of iron, calcium and lipid peroxidationCell Death & Differentiation, 2020
- DNA methylation profiling of asbestos-treated MeT5A cell line reveals novel pathways implicated in asbestos responseArchives of Toxicology, 2018
- Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesotheliomaCancer Letters, 2017
- Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterationsNature Genetics, 2016
- Antioxidant role of human haptoglobinProteomics, 2004
- p53, p21 and metallothionein immunoreactivities in patients with malignant pleural mesothelioma: correlations with the epidemiological features and prognosis of mesotheliomas with environmental asbestos exposureRespiratory Medicine, 2001
- Thrombospondin-1 expression and clinical implications in malignant pleural mesotheliomaCancer, 1999